Drugs / FAST LACO-Stim CDH17 CAR-T
last change Dec 2024 re-read 3 minutes ago

FAST LACO-Stim CDH17 CAR-T

Developed for
biliary tract cancer · colorectal carcinoma · gastric cancer · pancreatic ductal adenocarcinoma
Investigated by
UTC Therapeutics Inc. · Zhejiang University

Trials 1

2025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT06937567 Dec 2024 → Mar 2028 expected biliary tract cancer, colorectal carcinoma, gastric cancer, pancreatic ductal adenocarcinoma Zhejiang University Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FAST LACO-Stim CDH17 CAR-T ClinicalTrials.gov intervention name — accepted as the source's own label NCT06937567 ↗
Route Intravenous “Intravenous infusion of FAST LACO-Stim CDH17 CAR-T cells” NCT06937567 ↗